SAN DIEGO--(BUSINESS WIRE)--Vividion publishes manuscript detailing the discovery and optimization of VVD-214, the company’s covalent inhibitor of WRN... .
Pharmacokinetic and pharmacodynamic data indicated that NDI-219216 achieved robust WRN target engagement for more than 24 hours at multiple dose levels ... WRN is a DNA helicase required for DNA ...